Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03875313 |
| Title | Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Calithera Biosciences, Inc |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35294 | United States | Details | |
| Winship Cancer Institute of Emory University | Atlanta | Georgia | 30322 | United States | Details | |
| University of Iowa | Iowa City | Iowa | 52242 | United States | Details | |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
| Columbia University | New York | New York | 10032 | United States | Details | |
| MD Anderson | Houston | Texas | 77030 | United States | Details | |
| South Texas Accelerated Research Therapeutics, LLC | San Antonio | Texas | 78229 | United States | Details | |
| Huntsman Cancer Institute | Salt Lake City | Utah | 20000 | United States | Details | |
| University of Wisconsin | Madison | Wisconsin | 53792 | United States | Details |